The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.
S-F
SF
Yip
C-C
CC
So
Ay-Y
AY
Chan
Hs-Y
HY
Liu
Ts-K
TsK
Wan
L-C
LC
Chan
D015331:Cohort Studies; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D053614:Janus Kinase 2; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000175:diagnosis / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000175:diagnosis*; D017354:Point Mutation; D055728:Primary Myelofibrosis / Q000150:complications* / Q000175:diagnosis / Q000235:genetics*; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D015996:Survival Rate
D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2